It’s common for the share price of a small-cap issue to rise sharply in the wake of a significant FDA approval for one of its drugs. In the case of NuPathe, Inc., the FDA’s recent approval of the company’s migraine headache patch called Zecurity caused a short-lived stock price pop, and then a pull back [...]
This is the largest topic on ewallstreeter. This topic aggregates news and investment advice from over 200 different news sources. It covers all the financial markets, collectively known as Wall Street, as well as international news which affects our markets.